期刊文献+

药物去势治疗乳腺癌的研究进展 被引量:2

下载PDF
导出
摘要 药物去势,是应用促黄体生成素释放激素类似物(LH-Rha)在垂体水平抑制雌激素的生成,从而降低或消除体内及癌组织内的雌激素(E2)水平来阻止乳腺癌细胞的生长,最终达到控制肿瘤生长的目的。它具有安全、有效、可逆的显著优势。现对药物去势治疗乳腺癌的历史、作用机制及其研究现状等综述如下。
出处 《现代肿瘤医学》 CAS 2007年第9期1353-1354,共2页 Journal of Modern Oncology
  • 相关文献

参考文献9

二级参考文献101

  • 1[1]Early Breast Cancer Trialists' Collaborative Group. Ovarian ablation in early breast cancer overview of the randomised trials[J].Lancet, 1996,348(9036): 1189.
  • 2[2]Pritchard KI. GnRH analogues and ovarian ablation: their integration in the adjuvant strategy [J ]. Recent Results Cancer Res,1998,1522: 85.
  • 3[3]Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women[J]. Lancet,1992,339(8784): 1.
  • 4[4]Cancer Research Campaign Breast Cancer Trials Group. Preliminary results from the cancer research campaign trial evaluating tamoxifen duration in women aged fifty years or older with breast cancer,current trials working party of the cancer research campaign breast cancer trials group [J]. J Natl Cancer Inst, 1996,88(24): 1834.
  • 5[5]Boccardo F,Rubagotti A,Amoroso D,et al. Italian breast cancer adjuvant chemo-hormone therapy cooperative group trials,GROCTA trials[J]. Recent Results Cancer Res, 1998,1524:53.
  • 6[6]Boccardo F, Rubagotti A, Perotta, er al. Ovarian ablation versus goserelin with or without tamoxifen in per-perimenopausal patient with advanced breast cancer: result of a multicentric Italy study[J]. Ann Oncol, 1994,5 (4): 337.
  • 7[7]Ravdin PM. Overview of randomized trials of systemic adjuvant therapy[J]. Cancer Treat Res,2000,103:157.
  • 8[8]Jonat W,Kaufmann M,Blamey RW,et al.A randomised study to compare the effect of the luteinising hormone releasing hormone (LHRH) analogue goserelin with or without tamoxifen in pre and perimenopausal patients with advanced breast cancer[J]. Eur J Cancer, 1995,31A(2): 137.
  • 9[9]Baum M. Tamoxifen-the treatment of choice,why look for alternatives? [J ]. Br J Cancer, 1998,78 ( suppl 4): 1.
  • 10[10]Cockshott ID. Clinical pharmacokinetics of goserelin[J]. Clin Pharmacokinet, 2000,39 ( 1 ): 27.

共引文献21

同被引文献18

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部